Tag Archives: Transcatheter Embolization and Occlusion Devices Market

Transcatheter Embolization and Occlusion Devices Market – Worldwide Market Shares, Strategies, and Forecasts 2016 to 2024

Transparency Market Research (www.transparencymarketresearch.com) has published a new market report titled, “Transcatheter Embolization and Occlusion Devices Market: (Product Type – Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverter Devices, Liquid Embolics, and Accessories; Application – Peripheral Vascular Disease, Neurology, Oncology, Urology, and Others; End-user – Hospitals, Ambulatory Surgical Centers, and Clinics) – Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2016–2024”. According to the report, the transcatheter embolization and occlusion devices market is projected to reach US$ 4,811.2 Mn in 2024 at a CAGR of 7.9% from 2016 to 2024.

The report provides detailed analysis of the current and emerging trends in the transcatheter embolization and occlusion devices market. The market size has been provided for product type, application, and end-user. Geographically, the market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Increase in adoption of minimally invasive surgeries due to technological innovations and rise in cancer prevalence is projected to drive the transcatheter embolization and occlusion devices market.

Read Full Report: http://www.transparencymarketresearch.com/pressrelease/transcatheter-embolization-occlusion-devices-market.htm

North America accounted for a major share of the transcatheter embolization and occlusion devices market in 2015 due to presence of major market players in the region. Most of the major players operating in the region have made a series of strategic acquisitions, which contributes to the increase in their market share. Increasing cancer prevalence in the region is the one of the key factors contributing to the growth of market. According to the American Cancer Society, over 1,658,370 new cancer cases were diagnosed and 589,430 cancer deaths reported in the U.S. in 2015. Well-established reimbursement policies by private or public organization for TEO devices is a major factor increasing the adoption of these devices in the region.

Europe was the second largest market for transcatheter embolization and occlusion devices in 2015 due to increasing adoption of minimally invasive procedures for treatment. Embolization procedures have fewer side effects due to their minimal invasive nature and faster wound healing process. Rising awareness among the patients regarding embolization procedures and its associated benefits such as short hospital stay and fast healing process also contributes to market growth. Technological innovations and significant product launches also drive the market in the region.

Asia Pacific is expected to expand at a high CAGR during the forecast period from 2016 to 2024. Large patient pool and rising awareness about transcatheter embolization procedures in the region are the key growth factor of the TEO devices market. The booming medical tourism driven by rising government support and incorporation of different schemes by government to avail better treatment for patients is also expected to propel the market in the region. Increase in the number of localized manufacturers and strengthening of distribution network in Asia Pacific due to growing economy offer significant benefits for market players regarding investment purpose. Moreover, increase in neurovascular diseases and rise in cancer prevalence in countries in Asia Pacific are projected to propel the market.

Get Free Sample Research Report:

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2242

Brazil dominated the TEO devices market in Latin America in 2015 and will be the focus area for market players due to large investments by government in health care infrastructure. Rising awareness among physicians about embolization and its benefits is anticipated to drive the TEO devices market in the region.

Middle East & Africa accounts for negligible share of the global transcatheter embolization and occlusion devices market due to low availability of treatment options and lesser awareness among the people. However, global players have been entering Middle East & Africa through various distribution agreements to enhance the reach of their products and to establish their foothold in the region.

Key players operating in the global transcatheter embolization and occlusion devices market include Medtronic, Cook Medical, Terumo Corporation, Boston Scientific, Johnson & Johnson (DePuy Synthes), and Abbott Laboratories.

 

Asia Pacific Transcatheter Embolization and Occlusion Devices Market to expand at Impressive CAGR during Forecast Period

Transcatheter Embolization and Occlusion Devices Market: Snapshot

The transcatheter embolization and occlusion (TEO) devices market has witnessed strong growth in the past few years due to the rising focus on innovation, resulting in higher product approvals and product launches globally. The market is also characterized by significant research and development leading to several technological innovations.

In terms of revenue, the global TEO devices market was valued at US$2.4 bn in 2015 and is projected to reach US$4.8 bn by 2024 at a CAGR of 7.9% therein. In terms of volume, the global market is anticipated to register a CAGR of 8.1% from 2016 to 2024.

High Prevalence of Obesity Drives Use of TEO Devices in Treating Peripheral Vascular Diseases

Embolization coils are the leading products in the market, as these are one of the oldest embolization products available in the market. However, the embolization particles and flow diverter devices segments are expected to record a high CAGR during the forecast period.

Read Full Report: http://www.transparencymarketresearch.com/pressrelease/transcatheter-embolization-occlusion-devices-market.htm

Based on application, the peripheral vascular disease segment dominates the transcatheter embolization and occlusion devices market. This segment is expected to continue its lead through 2024 due to a growing geriatric population, changing lifestyles leading to a high prevalence of obesity, and the rising demand for minimally-invasive procedures. However, the oncology segment is expected to record a high CAGR during the forecast period due to the rising prevalence of cancer across the globe.

By end use, the hospitals segment captured a considerable market share and is likely to remain a key segment in the transcatheter embolization and occlusion devices market, expanding at a high CAGR during the forecast period.

Booming Medical Tourism Industry Contributing toward Growth of APAC TEO Devices Market

North America accounted for a major share in the global transcatheter embolization and occlusion devices market in 2015 due to the presence of leading market players in the region. Most of these companies operating in the region have made a series of strategic acquisitions, which contributes to an increase in their market share. The growing prevalence of cancer in the region is one of the primary factors contributing to the growth of the transcatheter embolization and occlusion devices market. According to the American Cancer Society, over 1,658,370 new cancer cases were diagnosed and 589,430 cancer deaths reported in the U.S. in 2015 alone. Well-established reimbursement policies by private or public organizations for TEO devices is also a major factor spurring the adoption of these devices North America.

Get Free Sample Research Report:

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2242

The transcatheter embolization and occlusion devices market in Asia Pacific is expected to expand at a high CAGR during the forecast period. A large patient pool and rising awareness about transcatheter embolization procedures are the key factors driving the adoption of TEO devices in the region. The booming medical tourism industry, driven by rising government support and the incorporation of different schemes by the government to avail better treatment for patients, is also expected to propel the transcatheter embolization and occlusion devices market. An increase in the number of localized manufacturers and the strengthening of the distribution network in Asia Pacific due to a rapidly growing economy offer significant benefits for market players as far as investments are concerned. A surge in the prevalence of neurovascular diseases and cancer in several countries across Asia Pacific is projected to fuel the market in the coming years.

Major players operating in the transcatheter embolization and occlusion devices market include Abbott Laboratories, Boston Scientific Corporation, BTG plc, Cook Medical, Inc., Edwards Lifesciences, Johnson & Johnson, Medtronic plc, Merit Medical Systems, Inc., Penumbra, Inc., Pfizer, Inc., Sirtex Medical Limited, St. Jude Medical, Inc., Stryker Corporation, and Terumo Corporation.

Increased Adoption of Minimally Invasive Surgeries to Drive Demand for Transcatheter Embolization and Occlusion Devices, finds TMR

Transparency Market Research (www.transparencymarketresearch.com) has published a new market report titled, “Transcatheter Embolization and Occlusion Devices Market: (Product Type – Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverter Devices, Liquid Embolics, and Accessories; Application – Peripheral Vascular Disease, Neurology, Oncology, Urology, and Others; End-user – Hospitals, Ambulatory Surgical Centers, and Clinics) – Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2016–2024”. According to the report, the transcatheter embolization and occlusion devices market is projected to reach US$ 4,811.2 Mn in 2024 at a CAGR of 7.9% from 2016 to 2024.

The report provides detailed analysis of the current and emerging trends in the transcatheter embolization and occlusion devices market. The market size has been provided for product type, application, and end-user. Geographically, the market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Increase in adoption of minimally invasive surgeries due to technological innovations and rise in cancer prevalence is projected to drive the transcatheter embolization and occlusion devices market.

North America accounted for a major share of the transcatheter embolization and occlusion devices market in 2015 due to presence of major market players in the region. Most of the major players operating in the region have made a series of strategic acquisitions, which contributes to the increase in their market share. Increasing cancer prevalence in the region is the one of the key factors contributing to the growth of market. According to the American Cancer Society, over 1,658,370 new cancer cases were diagnosed and 589,430 cancer deaths reported in the U.S. in 2015. Well-established reimbursement policies by private or public organization for TEO devices is a major factor increasing the adoption of these devices in the region.

Europe was the second largest market for transcatheter embolization and occlusion devices in 2015 due to increasing adoption of minimally invasive procedures for treatment. Embolization procedures have fewer side effects due to their minimal invasive nature and faster wound healing process. Rising awareness among the patients regarding embolization procedures and its associated benefits such as short hospital stay and fast healing process also contributes to market growth. Technological innovations and significant product launches also drive the market in the region.

Asia Pacific is expected to expand at a high CAGR during the forecast period from 2016 to 2024. Large patient pool and rising awareness about transcatheter embolization procedures in the region are the key growth factor of the TEO devices market. The booming medical tourism driven by rising government support and incorporation of different schemes by government to avail better treatment for patients is also expected to propel the market in the region. Increase in the number of localized manufacturers and strengthening of distribution network in Asia Pacific due to growing economy offer significant benefits for market players regarding investment purpose. Moreover, increase in neurovascular diseases and rise in cancer prevalence in countries in Asia Pacific are projected to propel the market.

Get Free Sample Research Report:

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2242

Brazil dominated the TEO devices market in Latin America in 2015 and will be the focus area for market players due to large investments by government in health care infrastructure. Rising awareness among physicians about embolization and its benefits is anticipated to drive the TEO devices market in the region.

Middle East & Africa accounts for negligible share of the global transcatheter embolization and occlusion devices market due to low availability of treatment options and lesser awareness among the people. However, global players have been entering Middle East & Africa through various distribution agreements to enhance the reach of their products and to establish their foothold in the region.

Key players operating in the global transcatheter embolization and occlusion devices market include Medtronic, Cook Medical, Terumo Corporation, Boston Scientific, Johnson & Johnson (DePuy Synthes), and Abbott Laboratories.

Increased Adoption of Minimally Invasive Surgeries to Drive Demand for Transcatheter Embolization and Occlusion Devices, finds TMR

Transcatheter Embolization and Occlusion Devices Market: Snapshot

The transcatheter embolization and occlusion (TEO) devices market has witnessed strong growth in the past few years due to the rising focus on innovation, resulting in higher product approvals and product launches globally. The market is also characterized by significant research and development leading to several technological innovations.

In terms of revenue, the global TEO devices market was valued at US$2.4 bn in 2015 and is projected to reach US$4.8 bn by 2024 at a CAGR of 7.9% therein. In terms of volume, the global market is anticipated to register a CAGR of 8.1% from 2016 to 2024.

High Prevalence of Obesity Drives Use of TEO Devices in Treating Peripheral Vascular Diseases

Embolization coils are the leading products in the market, as these are one of the oldest embolization products available in the market. However, the embolization particles and flow diverter devices segments are expected to record a high CAGR during the forecast period.

Based on application, the peripheral vascular disease segment dominates the transcatheter embolization and occlusion devices market. This segment is expected to continue its lead through 2024 due to a growing geriatric population, changing lifestyles leading to a high prevalence of obesity, and the rising demand for minimally-invasive procedures. However, the oncology segment is expected to record a high CAGR during the forecast period due to the rising prevalence of cancer across the globe.

By end use, the hospitals segment captured a considerable market share and is likely to remain a key segment in the transcatheter embolization and occlusion devices market, expanding at a high CAGR during the forecast period.

Booming Medical Tourism Industry Contributing toward Growth of APAC TEO Devices Market

North America accounted for a major share in the global transcatheter embolization and occlusion devices market in 2015 due to the presence of leading market players in the region. Most of these companies operating in the region have made a series of strategic acquisitions, which contributes to an increase in their market share. The growing prevalence of cancer in the region is one of the primary factors contributing to the growth of the transcatheter embolization and occlusion devices market. According to the American Cancer Society, over 1,658,370 new cancer cases were diagnosed and 589,430 cancer deaths reported in the U.S. in 2015 alone. Well-established reimbursement policies by private or public organizations for TEO devices is also a major factor spurring the adoption of these devices North America.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2242

The transcatheter embolization and occlusion devices market in Asia Pacific is expected to expand at a high CAGR during the forecast period. A large patient pool and rising awareness about transcatheter embolization procedures are the key factors driving the adoption of TEO devices in the region. The booming medical tourism industry, driven by rising government support and the incorporation of different schemes by the government to avail better treatment for patients, is also expected to propel the transcatheter embolization and occlusion devices market. An increase in the number of localized manufacturers and the strengthening of the distribution network in Asia Pacific due to a rapidly growing economy offer significant benefits for market players as far as investments are concerned. A surge in the prevalence of neurovascular diseases and cancer in several countries across Asia Pacific is projected to fuel the market in the coming years.

Major players operating in the transcatheter embolization and occlusion devices market include Abbott Laboratories, Boston Scientific Corporation, BTG plc, Cook Medical, Inc., Edwards Lifesciences, Johnson & Johnson, Medtronic plc, Merit Medical Systems, Inc., Penumbra, Inc., Pfizer, Inc., Sirtex Medical Limited, St. Jude Medical, Inc., Stryker Corporation, and Terumo Corporation.

 

Transcatheter Embolization and Occlusion Devices Market – Segment and Forecast till 2019

Transcatheter embolization and occlusion devices are used for non surgical procedures with minimal invasions generally performed by interventional radiologists or neuro-radiologists. Procedures through such devices involve introduction of emboli for selectively occluding the blood vessels. Embolization prevents blood flow to a particular body part or area to achieve effective shrinkage of a tumor or block an aneurysm. It is also used to treat various types of hemorrhages as well as management of malignant hypertension caused due to renal failure.

Early buyers will receive 10% customization on reports :- http://www.transparencymarketresearch.com/transcatheter-embolization-occlusion-devices-market.html

The global transcatheter embolization and occlusion devices market is categorized on the basis of:

  • Indication
  • Interventional neuro-radiology
  • Peripheral vascular (PV) tumors
  • Product type
  • Embolization coils
  • Coiling-assist devices
  • Flow-diverting devices
  • PV embolization coil
  • PV plugs
  • Embolization particles
  • Liquid embolics
  • Accessories

Currently, North America dominates the global transcatheter embolization and occlusion devices market and is followed by Europe due to the high success rate achieved in clinical trials and release of new devices thus leading to expansion of treatable patient population. Emerging economies of Asia, Middle East and Latin America are also expected to show rapid growth in this market due growth in the graying population and associated susceptibility to cancer and cardiovascular diseases in these regions.
Some of the major factors driving the global market for transcatheter embolization and occlusion devices include high adoption rates for non-surgical and growing popularity of the minimal invasive procedure, minimal risk associated with such procedures and faster recovery time and aging population worldwide. However, dicey reimbursement policies in less developing nations may pose a challenge to the growth of transcatheter embolization and occlusion devices market.

Some of the key players contributing to this market include Abbott Laboratories, Inc., Boston Scientific Corporation, Cook Medical, Cordis Corporation, ev3, Inc., Eisai Co. Ltd., Mallinckrodt LLC, Medtronic, Inc., Terumo Corporation and Marine Polymer Technologies, Inc.

Enquiry Before Buying :- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2242

Browse Market Research Blog:
http://researchreportsindustry.blogspot.com/